Ultrasonic Pneumatic Lithotripter Market Seen Reaching $0.36 Billion by 2030

The ultrasonic pneumatic lithotripter market is forecast to rise from $0.26 billion in 2025 to $0.36 billion by 2030, driven by more kidney stone cases, more minimally invasive procedures and broader hospital investment. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Ultrasonic pneumatic lithotripters are used to break urinary tract stones during minimally invasive urological procedures. - Market growth signals rising demand for faster stone removal, shorter procedures and less invasive treatment options. - The market outlook reflects wider investment in urology infrastructure and outpatient care.

What happened: - The ultrasonic pneumatic lithotripter market is projected to grow from $0.26 billion in 2025 to $0.28 billion in 2026. - The market is forecast to reach $0.36 billion by 2030. - The report puts the market on a 6.5% CAGR in 2026 and a 6.7% CAGR through 2030. - North America held the largest share of the market in 2025. - Asia-Pacific is expected to be the fastest-growing region over the forecast period.

The details: - The device uses ultrasonic vibrations and pneumatic shock waves to fragment stones into smaller pieces for removal. - The technology is designed to improve stone clearance, reduce tissue damage and shorten recovery times. - Growth in the near term is linked to the rising incidence of urinary stone disease. - More endourological procedures are supporting demand. - Preference for minimally invasive urological treatments is also expanding the market. - Better availability of advanced urology devices is contributing to adoption. - Greater awareness of stone management techniques is supporting use. - By 2030, growth is expected to be supported by demand for outpatient stone treatment. - Investments in urology infrastructure are expected to increase. - Wider adoption of integrated lithotripsy platforms is part of the forecast. - Higher healthcare spending on minimally invasive technologies is expected to add support. - The rise in specialized urology centers is another driver. - The report highlights growing use of combined ultrasonic pneumatic stone fragmentation systems. - The report also points to stronger demand for high-efficiency stone disintegration technologies. - Suction-assisted lithotripsy is expected to see broader application. - Pressure to shorten endourological procedure times is shaping product and workflow trends. - Kidney stone disease is a major driver because the condition can cause severe pain, blockages and urinary complications. - Rising obesity, diabetes, unhealthy diets and dehydration are increasing kidney stone incidence. - In March 2026, National Institutes of Health data showed the pooled prevalence of kidney stones in Europe at about 7.2%. - Expansion of healthcare infrastructure is also supporting demand. - In May 2025, the UK Government Property Function reported a 1.2% increase in the health estate to about 7,400 primary, secondary and community healthcare properties in 2023–24. - Broader use of minimally invasive procedures is reinforcing the market. - The American Society of Plastic Surgeons reported 5.29 million minimally invasive procedures involving hyaluronic acid fillers in 2023, up 8% from the prior year. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report edition includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology and future-trend analysis, and updated graphics and tables. - A free sample of the market report is available. - The full market report is also available. - The Business Research Company listed contact details for Saumya Sahay, including phone numbers and marketing@tbrc.info.

Between the lines: - The report ties medical-device demand to broader shifts in health systems, not just to stone-disease prevalence. - The strongest signals point to outpatient care, minimally invasive techniques and workflow efficiency as the main purchasing priorities. - Regional growth expectations suggest mature-market leadership in North America and faster expansion opportunities in Asia-Pacific.

What's next: - The market is expected to keep expanding as hospitals and specialty centers invest in endourology capabilities. - Adoption should rise where providers are prioritizing shorter procedures, lower invasiveness and integrated stone-removal systems. - The company is positioning the 2026 report as a planning tool with forecasting dashboards and hotspot analysis.